Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a patient suffered a serious side effect or if the illness had nothing to do with the shot.
In a statement issued Tuesday evening, the company said its “standard review process triggered a pause ...
from www.washingtontimes.com stories: Business & Economy https://ift.tt/32aQrWp
AstraZeneca COVID-19 vaccine study paused after one illness
Reviewed by Riyad
on
September 08, 2020
Rating:
No comments: